The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter study of the impact of trial eligibility criteria on enrollment to KRAS G12C inhibitor trials in patients with non-small cell lung cancer.
 
Michael May
No Relationships to Disclose
 
Margaux Wooster
No Relationships to Disclose
 
Prashasti Agrawal
Honoraria - MJH Life Sciences
 
Jonathan Lee
No Relationships to Disclose
 
Benjamin May
No Relationships to Disclose
 
Xin Ma
No Relationships to Disclose
 
Stephanie Bogdan
No Relationships to Disclose
 
Catherine Shu
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Gilead Sciences; Janssen; Takeda
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Janssen (Inst)
 
Brian Henick
Honoraria - DAVA Oncology; OncLive/MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; IDEAYA Biosciences; Jazz Pharmaceuticals; Regeneron; Sorrento Therapeutics; Synthekine
Research Funding - Genentech/Roche (Inst); Johnson & Johnson/Janssen (Inst); NexImmune (Inst); Stand Up 2 Cancer (Inst); V Foundation (Inst)
 
Anjali Saqi
Honoraria - Medscape
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Genentech/Roche; Gilead Sciences
Research Funding - Boehringer Ingelheim (Inst); Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Calculator Tool (Inst); Cell block patent (Inst)
 
Mahesh Mansukhani
Travel, Accommodations, Expenses - Bristol-Myers Squibb; E.R. Squibb Sons, LLC; Promega
 
Gregory Riely
Honoraria - Dava Oncology
Research Funding - Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Patent application submitted covering pulsatile use of erlotinib to treat or prevent brain metastases (Inst)
Travel, Accommodations, Expenses - Bayer; Merck
Other Relationship - Mirati Therapeutics; Pfizer; Roche/Genentech; Takeda
 
Dawn Hershman
Consulting or Advisory Role - AIM Specialty Health
 
Christine Garcia
Honoraria - Johnson & Johnson/Janssen; Pfizer; Regeneron
Consulting or Advisory Role - Pfizer
 
Kathryn Arbour
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Genzyme; Lilly; Merck; Novartis; Regeneron; Revolution Medicines; Sanofi
Research Funding - Bristol Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Revolution Medicines (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb; Revolution Medicines
 
Benjamin Herzberg
Honoraria - Boxer Capital; Eisai; IDEOlogy Health; OncLive/MJH Life Sciences
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Daiichi-Sankyo; IDEAYA Biosciences; Johnson and Johnson; Lilly
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca; IDEAYA Biosciences (Inst); Lilly (Inst); Monte Rosa Therapeutics (Inst); Nested Therapeutics (Inst); Prelude Therapeutics (Inst); Repare Therapeutics (Inst); Revolution Medicines (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - DAVA Oncology